ArticleFrontiers in bioengineering and biotechnology2021
Enhancing Cellular Infiltration on Fluffy Polyaniline-Based Electrospun Nanofibers.
Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 28 citations in OpenAlex.
- Optimisation of electrospinning parameters to successfully obtain high ratios of medium chain length polyhydroxyalkanoate in electrospun fibres with drug loading for wound healing applications.Journal of materials science. Materials in medicine · 2026Article
- Evaluating and improving biocompatibility of conductive polymers for cardiac tissue engineering.Journal of materials chemistry. B · 2026Review
- Fabrication and Characterization of Electrospun Sr/Zn-Doped Nano-Hydroxyapatite-Collagen-PLGA Nanofibrous Scaffolds for Bone Tissue Engineering.International journal of nanomedicine · 2025Article
- PCL-based 3D nanofibrous structure with well-designed morphology and enhanced specific surface area for tissue engineering application.Progress in biomaterials · 2023Article
- Preparation of Fucoidan-Based Electrospun Nanofibers and Their Interaction With Endothelial Cells.Frontiers in bioengineering and biotechnology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the unique properties of polyaniline (PANI), the processability of this smart polymer is associated with challenges. Particularly, it is very difficult to prepare PANI nanofibers due to poor solubility, high charge density, and rigid backbone. The most common approach for solving this problem is blending PANI with a carrier polymer. Furthermore, the major limitations of nanofibers for tissue engineering applications are their low porosity and two-dimensional (2D) structure. In this study, conductive nanofibers were fabricated through electrospinning of PANI/poly(ether sulfone) (PES) with different solvents including dimethyl sulfoxide (DMSO), N-methyl-2-pyrrolidone (NMP), and hexafluoroisopropanol (HFIP). The effect of solvent, carrier polymer (PES), and PANI content on formation of 3D conductive nanofibers with appropriate porosity were investigated. It was shown that a solvent with suitable properties should be selected in such a way that the composite nanofibers can be electrospun at the lowest concentration of PES. In this way, the ratio of PANI increased in the scaffold, the electrical conductivity of nanofibers enhanced, and the flat 2D structure of scaffold changed to a fluffy 3D structure. Among the three studied solvents, HFIP with the lowest boiling point and the lowest surface tension was the best solvent for the fabrication of PANI/PES nanofibers. PES could be electrospun at a concentration of 9% w/w in HFIP, while the optimum percentage of PES in DMSO and NMP was above 23% w/w to produce uniform nanofibers. 3D nanofibrous scaffold obtained from 0.5% PANI/9% PES/HFIP solution with electrical conductivity of 3.7 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.